Squamous cell carcinoma in situ. Photo by Klaus D. Peter via Wikimedia Commons Findings from a preclinical study show a topical cream that blocks the immune-suppressing enzyme LSD1 suppressed tumour growth in two models of cutaneous squamous cell carcinoma (cSCC). The study, published in the  Journal of Clinical Investigation ,  describes how the cream, developed by researchers at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, prevents LSD1

New research shows that adults with atopic dermatitis (AD) have a 34% increased risk of developing new-onset inflammatory bowel disease...

People with lighter skin tones may be more susceptible to melanoma not only due to a lack of UV-protective melanin, but because of a lack...

Findings from a qualitative study in women with adult acne show that the skin condition leads to strong concerns about appearance. As...

In a U.S. study of store-and-forward teledermatology, adoption of the system by primary care practitioners reduced the response time for...